The role of histone methylation in renal cell cancer: an update

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Renal cell carcinoma (RCC) represents 2-3% of all cancer diagnoses.
• Early diagnosis of RCC remains a significant clinical challenge.
• Genome-wide studies highlight histone methylation as a frequently dysregulated functional class in RCC.

Purpose of the Study:

• To summarize the current understanding of histone methylations, demethylases, and their alterations in renal cell cancer.
• To elucidate the mechanisms by which these epigenetic modifications influence gene expression and tumor progression in RCC.
• To provide a comprehensive overview for researchers and clinicians focused on RCC epigenetics.

Main Methods:

• Review of recent genome-wide studies and relevant literature.
• Analysis of data on mutations and mis-regulation of histone-modifying enzymes.
• Synthesis of information on the functional impact of epigenetic alterations in RCC.

Main Results:

• Histone methylation is a common epigenetic abnormality in renal cell cancer.
• Mutations or mis-regulation of histone methyltransferases and demethylases are linked to altered gene expression.
• These epigenetic changes are associated with the progression of renal cell cancer.

Conclusions:

• Epigenetic dysregulation, particularly in histone methylation, plays a significant role in renal cell cancer pathogenesis.
• Targeting histone-modifying enzymes presents a potential avenue for future therapeutic strategies in RCC.
• Further research into the specific mechanisms of histone methylation alterations is warranted for improved RCC management.